April 22, 2026 | Volume XV | Issue 16

Evaluating the credibility of major medical journals today

Laurel A. Coons, PhD writes for KevinMD:


In recent months, a heated debate has emerged about the credibility of major medical journals such as the New England Journal of Medicine, the Journal of the American Medical Association, and The Lancet. Critics, including United States Health and Human Services Secretary Robert F. Kennedy Junior, have argued that these journals are compromised by pharmaceutical industry influence and therefore cannot be trusted. At first glance, the claim may...

Read More

Marty Makary: A quiet blockade on safer nicotine

Roger Bate


There are moments in public health when the path forward is unusually clear, when the evidence aligns with behavior, when risks are well understood, and when policy has a genuine opportunity to reduce harm at scale. This should be one of those moments.


Non-combustible nicotine products—vapes, heated tobacco, and especially nicotine pouches—are widely understood to be far less harmful than smoking, a point I and many others have covered repeatedly, and one that no longer sits at the frontier of scientific debate. At the same time, the political panic that once drove restrictive policy has subsided, with youth vaping falling sharply from its peak.


The most recent data show that around 5.2 percent of youth report e-cigarette use in the past 30 days, down dramatically from prior highs, and importantly only a subset of that group are frequent users, those using on 20 or more days in a month, the category most closely associated with dependence.

Read More

Physician burnout improving but some specialties lag

American Medical Association reports:


New data from the American Medical Association (AMA) show physician burnout continuing to decline nationwide, but significant differences across medical specialties underscore the need for more targeted solutions within health systems.


In 2025, 41.9% of physicians reported experiencing at least one symptom of burnout...

Read More

Pancreatic cancer patients thrive after promising mRNA vaccine

First Alert 6 via YouTube


CNN Health Reporter Jacqueline Howard explains how an mRNA-based vaccine is showing promising results as a potential treatment approach for pancreatic cancer, with some patients doing well in early research. Here’s what researchers are looking at and why the findings are generating optimism—while noting more study is needed.

View video HERE.

Publisher of Week in Review, Specialty Focus, FHIweekly & Game Changers